Amicogen, Inc.

₩959.00As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:092040Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (21.64%)
Div yield 2.61%
ROE (16.77%)
Biotechnology
Beta (5Y) 0.12
PE TTM —
TSR TTM (68.45%)
Mkt cap ₩67.56B
ROIC (7.86%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,049
9.44%
21.50%
Sell 5|0|1|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
12.28
12.45
13.77
13.76
34.96%
27.42%
37.78%
22.96%
Revenue₩B
8.886
8.868
8.922
9.315
7.80%
3.49%
3.76%
7.49%
Peers (US$49.81M)
Cap (US$)
PE
33.87M
—
49.72M
—
Capital
TTM
5Y
10Y
Leveragex
1.003
0.117
0.125
EBIT/Intx
0.945
0.064
0.060
Own earn%
(7.38)
(219.21)
(192.55)
Sh yield%
15.81
54.84
50.91
Owners
Insiders/Inst%
1.66
60.93
Short interest%
5.71
SBC / revenue%
0.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
21–24
$1 testx
−1.4
Incr. ROIC%
6